FORMULA-509 probes salvage radiation and gonadotropin-releasing hormone routine

March 16, 2023

5 min watch

Nguyen studies consulting for Bayer, Blue Earth Diagnostics, Boston Clinical, Janssen Oncology and Myovant Sciences; and receiving analysis investment from Astellas Pharma, Bayer and Janssen.

We have been not able to procedure your request. Please take a look at once more later. In the event you proceed to have this factor please touch [email protected].

On this video, Paul Nguyen, MD, a genitourinary radiation oncologist at Dana-Farber Most cancers Institute, discusses the FORMULA-509 trial he co-presented at ASCO Genitourinary Cancers Symposium.

The learn about tested sufferers with a emerging PSA after radical prostatectomy who had no less than one negative chance issue, and who gained salvage radiation and six months of a gonadotropin-releasing hormone agonist.

“What I feel we will say now could be for a affected person lately, the usage of the FORMULA-509 routine is an excessively horny selection to having to elongate the length of hormone remedy to 24 months,” Nguyen mentioned.


  • Nguyen P, et al. FORMULA-509: A multicenter randomized trial of post-operative salvage radiotherapy (SRT) and six months of GnRH agonist without or with abiraterone acetate/prednisone (AAP) and apalutamide (Apa) post-radical prostatectomy (RP). Introduced at: ASCO Genitourinary Cancers Symposium; ; Feb. 16-18, 2023; San Francisco.

Like this post? Please share to your friends:
Leave a Reply

;-) :| :x :twisted: :smile: :shock: :sad: :roll: :razz: :oops: :o :mrgreen: :lol: :idea: :grin: :evil: :cry: :cool: :arrow: :???: :?: :!: